NCT05729438 Nutritional Assesment in Patients With Cirrhosis
| NCT ID | NCT05729438 |
| Status | Recruiting |
| Phase | — |
| Sponsor | SUUMC Central Military Hospital Dr Carol Davila |
| Condition | Cirrhosis, Liver |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluated nutritional status in patiets with cirrhosis
Eligibility Criteria
Inclusion Criteria: * signed informed consent * age \>18, \<75 years old * hepatic cirrhosis diagnosis Exclusion Criteria: * refuse to participate/to give consent * presence of musculo-skeletal disease previous diagnosed, neuropathic diseases, malignancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05729438 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Cirrhosis, Liver. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05729438 currently recruiting?
Yes, NCT05729438 is actively recruiting participants. Contact the research team at bucuricasandy@yahoo.com for enrollment information.
Where is the NCT05729438 trial being conducted?
This trial is being conducted at Bucharest, Romania.
Who is sponsoring the NCT05729438 clinical trial?
NCT05729438 is sponsored by SUUMC Central Military Hospital Dr Carol Davila. The trial plans to enroll 50 participants.